| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.14B | 32.82B | 31.00B | 30.12B | 26.80B | 26.14B |
| Gross Profit | 11.22B | 12.29B | 10.36B | 10.17B | 9.06B | 9.37B |
| EBITDA | 5.24B | 5.71B | 5.29B | 5.12B | 4.34B | 4.53B |
| Net Income | -563.46M | 2.11B | 450.96M | 1.78B | 1.62B | 1.76B |
Balance Sheet | ||||||
| Total Assets | 41.64B | 37.48B | 38.66B | 38.58B | 36.92B | 35.56B |
| Cash, Cash Equivalents and Short-Term Investments | 11.27B | 8.74B | 12.31B | 9.45B | 7.57B | 12.21B |
| Total Debt | 2.34B | 2.38B | 2.71B | 3.08B | 3.34B | 3.47B |
| Total Liabilities | 15.10B | 13.14B | 13.64B | 13.00B | 12.48B | 12.11B |
| Stockholders Equity | 26.48B | 23.61B | 24.97B | 25.54B | 24.40B | 23.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.62B | 3.98B | 4.79B | 3.49B | 3.69B |
| Operating Cash Flow | 0.00 | 3.53B | 4.29B | 5.33B | 3.60B | 3.84B |
| Investing Cash Flow | 0.00 | -3.72B | 597.43M | -1.71B | -6.48B | -1.61B |
| Financing Cash Flow | 0.00 | -3.40B | -2.01B | -1.75B | -1.76B | -2.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥3.67B | 19.86 | ― | 1.93% | 2.69% | 8.14% | |
71 Outperform | ¥115.23B | 21.77 | 19.59% | 0.16% | 19.44% | 45.06% | |
66 Neutral | ¥1.18T | 12.01 | 7.04% | 1.47% | 3.77% | -0.57% | |
65 Neutral | ¥27.81B | 13.62 | ― | 3.97% | 5.89% | 370.39% | |
64 Neutral | ¥38.64B | 11.25 | ― | 3.71% | -1.77% | 22.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥1.19T | 18.08 | 6.28% | 1.07% | 5.07% | -24.11% |